CIP2A coordinates phosphosignaling, mitosis, and the DNA damage response

Srikar Nagelli, Jukka Westermarck*

*Korresponderande författare för detta arbete

Forskningsoutput: TidskriftsbidragÖversiktsartikelPeer review

1 Citeringar (Scopus)
5 Nedladdningar (Pure)

Sammanfattning

Human cancers share requirements for phosphorylation-dependent signaling, mitotic hyperactivity, and survival after DNA damage. The oncoprotein CIP2A (cancerous inhibitor of PP2A) can coordinate all these cancer cell characteristics. In addition to controlling cancer cell phosphoproteomes via inhibition of protein phosphatase PP2A, CIP2A directly interacts with the DNA damage protein TopBP1 (topoisomerase II-binding protein 1). Consequently, CIP2A allows DNA-damaged cells to enter mitosis and is essential for mitotic cells that are defective in homologous recombination (HR)-mediated DNA repair (e.g., BRCA mutants). The CIP2A-TopBP1 complex is also important for clustering fragmented chromosomes at mitosis. Clinically, CIP2A is a disease driver for basal-like triple-negative breast cancer (BL-TNBC) and a promising cancer therapy target across many cancer types.

OriginalspråkEngelska
Sidor (från-till)52-64
Antal sidor13
TidskriftTrends in Cancer
Volym10
Nummer1
DOI
StatusPublicerad - jan. 2024
MoE-publikationstypA2 Granska artikel i en vetenskaplig tidskrift

Fingeravtryck

Fördjupa i forskningsämnen för ”CIP2A coordinates phosphosignaling, mitosis, and the DNA damage response”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här